VKH
ATRS

Virtu KCG Holdings’s Antares Pharma, Inc. ATRS Stock Holding History

Virtu KCG Holdings’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$62K Sell
19,186
-47,531
-71% -$135K ﹤0.01% 2539
2017
Q1 		$189K Buy
66,717
+21,881
+49% +$52.6K 0.01% 2462
2016
Q4 		$104K Buy
44,836
+5,383
+14% +$10.3K ﹤0.01% 2900
2016
Q3 		$66K Buy
+39,453
New +$48.3K ﹤0.01% 2737
2016
Q1 		– Sell
-51,333
Closed -$62K – 3882
2015
Q4 		$62K Buy
51,333
+36,117
+237% +$50.3K ﹤0.01% 3117
2015
Q3 		$26K Sell
15,216
-2,096
-12% -$4.11K ﹤0.01% 3114
2015
Q2 		$36K Sell
17,312
-10,502
-38% -$25.5K ﹤0.01% 3122
2015
Q1 		$75K Buy
27,814
+10,688
+62% +$27.1K ﹤0.01% 2724
2014
Q4 		$44K Sell
17,126
-81,508
-83% -$183K ﹤0.01% 3473
2014
Q3 		$181K Buy
+98,634
New +$215K ﹤0.01% 2968
2014
Q2 		– Sell
-50,728
Closed -$177K – 4173
2014
Q1 		$177K Buy
50,728
+34,904
+221% +$155K ﹤0.01% 3047
2013
Q4 		$71K Sell
15,824
-58,426
-79% -$238K ﹤0.01% 3531
2013
Q3 		$302K Buy
+74,250
New +$324K ﹤0.01% 2611

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu KCG Holdings's ATRS Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Antares Pharma, Inc. (ATRS) stake by 71% in Q2 2017, selling an estimated $135K and leaving 19,186 shares worth $62K. The position accounts for ﹤0.01% of the portfolio, ranked #2539.

Virtu KCG Holdings first reported a position in ATRS in Q3 2013 and has held it in 13 quarters since. The position peaked at $302K in Q3 2013. 103 funds tracked by Wall St. Rank hold ATRS as of Q2 2017.

  • Virtu KCG Holdings held 19,186 shares of Antares Pharma, Inc. worth $62K as of Q2 2017.
  • Virtu KCG Holdings sold 47,531 Antares Pharma, Inc. shares in Q2 2017, an estimated $135K.
  • Antares Pharma, Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2539 holding.
  • Virtu KCG Holdings first reported a position in Antares Pharma, Inc. in Q3 2013 and has held it in 13 quarters since.
  • Virtu KCG Holdings's Antares Pharma, Inc. position peaked at $302K in Q3 2013.
  • 103 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.